Concepedia

Charles Ellars

CE

Statistics

Publications

7

Citations

232

H-Index

7

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Radboud University Nijmegen

Radboud University Medical Center

Charles Ellars is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and ligand binding.

Publications per year

2002–2007

7

Publications

7

Design, Synthesis, and Evaluation of Radiolabeled Integrin α <sub> <i>v</i> </sub> β <sub>3</sub> Receptor Antagonists for Tumor Imaging and Radiotherapy

Thomas D. Harris, Shirley Kalogeropoulos, Tiffany Nguyen et al. · Cancer Biotherapy and Radiopharmaceuticals · 2003 · 82 citations

, , +17

Comparison of Yttrium and Indium Complexes of DOTA-BA and DOTA-MBA:  Models for <sup>90</sup>Y- and <sup>111</sup>In-Labeled DOTA−Biomolecule Conjugates

Shuang Liu, John Pietryka, Charles Ellars et al. · Bioconjugate Chemistry · 2002 · 54 citations

, , +10

Structure−Activity Relationships of <sup>111</sup>In- and <sup>99m</sup>Tc-Labeled Quinolin-4-one Peptidomimetics as Ligands for the Vitronectin Receptor:  Potential Tumor Imaging Agents

Thomas D. Harris, Shirley Kalogeropoulos, Tiffany Nguyen et al. · Bioconjugate Chemistry · 2006 · 28 citations

, , +16

A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci.

Julliëtte E M van Eerd, Wim J.G. Oyen, Thomas D. Harris et al. · PubMed · 2003 · 27 citations

, , +14

Radiolabeled Divalent Peptidomimetic Vitronectin Receptor Antagonists as Potential Tumor Radiotherapeutic and Imaging Agents

Thomas D. Harris, Edward H. Cheesman, Anthony R. Harris et al. · Bioconjugate Chemistry · 2007 · 19 citations

, , +17

1–5 of 7